(Q34071896)

30 July 2017

1 reference

title

Metabolic abnormalities in cachexia and anorexia (English)

1 reference

30 July 2017

Tisdale MJ

1

1 reference

30 July 2017

publication date

1 October 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

16

1 reference

30 July 2017

issue

10

1 reference

30 July 2017

page(s)

1013-1014

1 reference

Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

A review of cancer cachexia and abnormal glucose metabolism in humans with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with and without cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

Studies of the mechanism of carcass fat depletion in experimental cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

A lipid mobilizing factor in serum of tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

Alterations in serum lipolytic activity of cancer patients with response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

Inhibition of tumour-induced lipolysis in vitro and cachexia and tumour growth in vivo by eicosapentaenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

Increased expression of the mRNA for hormone-sensitive lipase in adipose tissue of cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

Protein-calorie undernutrition in hospitalized cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

Skeletal muscle metabolism in patients with malignant tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

Protein synthesis in muscle measured in vivo in cachectic patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

Bioactivity of skeletal muscle proteolysis-inducing factors in the plasma proteins from cancer patients with weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

Characterization of a cancer cachectic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

Structural analysis of a tumor-produced sulfated glycoprotein capable of initiating muscle protein degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

Induction of muscle protein degradation by a tumour factor

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900409-3

7 January 2021

10.1016/S0899-9007(00)00409-3

Identifiers

DOI

1 reference

30 July 2017

1 reference